Pharmacoepidemiology and Drug Safety

Papers
(The H4-Index of Pharmacoepidemiology and Drug Safety is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Time‐related biases in pharmacoepidemiology74
Real‐world evidence to support regulatory decision‐making for medicines: Considerations for external control arms66
Rise and regional disparities in buprenorphine utilization in the United States43
Base de Datos para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP): A data resource for pharmacoepidemiology in Spain43
Accuracy of Japanese claims data in identifying diabetes‐related complications38
Control yourself: ISPE‐endorsed guidance in the application of self‐controlled study designs in pharmacoepidemiology34
Considerations for pharmacoepidemiological analyses in the SARS‐CoV‐2 pandemic33
CPRD Aurum database: Assessment of data quality and completeness of three important comorbidities31
Core concepts in pharmacoepidemiology: Confounding by indication and the role of active comparators30
QTc prolongation in COVID‐19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta‐analysis28
Methods for external control groups for single arm trials or long‐term uncontrolled extensions to randomized clinical trials27
Quality and completeness of diagnoses recorded in the new CPRD Aurum Database: evaluation of pulmonary embolism25
Analysis of immune‐related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database25
Validation of diagnosis codes to identify hospitalized COVID‐19 patients in health care claims data24
Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death23
Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006‐2016: A study in the five Nordic countries, United States, and Australia22
Identifying drugs with disease‐modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology21
A COVID‐19‐ready public health surveillance system: The Food and Drug Administration's Sentinel System21
Suicide‐related over‐the‐counter analgesic exposures reported to United States poison control centers, 2000‐201821
Randomized, observational, interventional, and real‐world—What's in a name?20
Genetic and clinical risk factors associated with phenytoin‐induced cutaneous adverse drug reactions in Thai population20
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID‐19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 320
0.063384056091309